Regulatory & Reimbursement
FDA Output October 2019
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, and Warning Letters in October 2019.
Read ArticleAbout
@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.